0001104659-20-094444.txt : 20200813 0001104659-20-094444.hdr.sgml : 20200813 20200813100438 ACCESSION NUMBER: 0001104659-20-094444 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 EFFECTIVENESS DATE: 20200813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 201097698 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET, SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET, SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001704132 XXXXXXXX 06-30-2020 06-30-2020 false Foresite Capital Management IV, LLC

600 Montgomery Street, Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 08-13-2020 0 12 205283 INFORMATION TABLE 2 infotable.xml Cymabay Therapeutics, Inc. COM 23257D103 9925 2843893 SH SOLE 2843893 0 0 Cytokinetics Incorporated COM 23282W605 37884 1607292 SH SOLE 1607292 0 0 Dicerna Pharmaceuticals, Inc. COM 253031108 635 25000 SH SOLE 25000 0 0 Fulcrum Therapeutics, Inc. COM 359616109 20740 1133948 SH SOLE 1133948 0 0 Generation Bio Co. COM 37148K100 18017 857942 SH SOLE 857942 0 0 Keros Therapeutics, Inc. COM 492327101 53567 1428071 SH SOLE 1428071 0 0 Kura Oncology, Inc. COM 50127T109 21320 1307982 SH SOLE 1307982 0 0 Myokardia, Inc. COM 62857M105 12222 126492 SH SOLE 126492 0 0 Oric Pharmaceuticals, Inc. COM 68622P109 4216 125000 SH SOLE 125000 0 0 Retrophin, Inc. COM 761299106 612 30000 SH SOLE 30000 0 0 Vaxcyte, Inc. COM 92243G108 19624 620821 SH SOLE 620821 0 0 Voyager Therapeutics, Inc. COM 92915B106 6521 516751 SH SOLE 516751 0 0